Following a monthslong interregnum at the U.S. Food and Drug Administration, the leadership pieces are again locking into ...
The US Food and Drug Administration (FDA) has announced the permanent appointment of four top officials to lead the agency's ...
Pharmaceutical Technology on MSN
HHS appoints permanent FDA CBER, CDER heads
The HHS sets out these permanent senior leadership positions as it looks to “reform” the FDA.
After almost two years of turnover in the FDA’s top ranks, the new appointments should help ease concerns about more turmoil ahead, one analyst said.
FDA’s Center for Biologics Evaluation and Research (CBER), the locus of regulating cell and gene therapies among other expanding areas of biotech, is poised for change on a number of important ...
Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research. Agency adviser Scott Steele, Ph.D., will take ...
CDER director George Tidmarsh will now also take responsibility for CBER at the FDA. The FDA has moved swiftly to fill the void left by Vinay Prasad's resignation as director of the Center for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results